SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
JULY 19, 2004
GenoMed, INC.
-------------
(Exact name of registrant as specified in its charter)
FLORIDA 000-49720 43-1916702
----------------------------- ------------------ ----------------------------
(State or other jurisdiction (Commission file (IRS Employer
of incorporation) number) Identification Number)
9666 Olive Blvd., Suite 310, St. Louis, Missouri 63132
------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
---------------------------------------------------
(314) 652-0500
909 South Taylor Avenue, St. Louis, Missouri 63110
--------------------------------------------------
(Former name or former address if changed since last report)
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT
(a) On July 19, 2004, the registrant's independent auditor, Stark Winter
Schenklin & Co., LLP ("SWS") of Denver, Colorado, was dismissed. The
decision to dismiss SWS was approved by the board of directors of the
registrant.
For fiscal year 2002, SWS issued a qualified opinion on the registrant's
financial statements, expressing "substantial doubt about the Company's
ability to continue as a going concern."
For the fiscal year 2003, SWS did not issue an adverse opinion, disclaimer
of opinion or modification or qualification of opinion on the registrant's
financial statements.
During the two most recent fiscal years of the registrant there has been no
disagreement with SWS on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which if
not resolved to the satisfaction of SWS, would have caused it to make
reference to the subject matter of the disagreement in connection with its
report.
The registrant has authorized SWS to respond fully to any inquiries of its
new auditor concerning any issue relating to the registrant's accounting
principles or practices or financial reporting, the registrant's financial
statements or SWS's audit thereof or audit opinions thereon.
The registrant has provided a copy of the disclosures in this report to
SWS. Any letter from SWS pursuant to paragraph (a)(3) of Regulation S-K
will be supplied by amendment.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
GenoMed, Inc.
Dated: July 22, 2004 By: /S/ David Moskowitz
---------------------------
Dr. David Moskowitz
Chairman of the Board and
Chief Executive Officer